Caprolactam Chemicals shareholders approve FY26 financials, auditor change

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Shareholders approved FY26 financial statements with 100% votes in favor
  • Zaver Shankarlal Bhanushali reappointed as director with unanimous support
  • Raman S Shah & Co appointed as statutory auditors for five-year term
  • Total 2,649,789 votes cast in favor across all three resolutions
powered bylight_fuzz_icon
52157737

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals shareholders approved the audited standalone financial statements for the fiscal year ended March 31, 2026, during the company's 37th Annual General Meeting (AGM).

The meeting, held virtually on September 28, 2026, also saw the reappointment of Zaver Shankarlal Bhanushali as a director and the appointment of Raman S Shah & Co as the new statutory auditors. Voting results released on September 29, 2026, confirm unanimous approval for all resolutions.

Key resolutions passed

The board presented three ordinary business items for shareholder approval. All resolutions were adopted following e-voting procedures mandated by SEBI regulations.

Resolution Details
Financial Statements Adoption of audited standalone financials for FY26
Director Reappointment Zaver Shankarlal Bhanushali (DIN: 00663374)
Auditor Appointment Raman S Shah & Co (ICAI Firm Reg: 111919W)

The newly appointed auditors will hold office for a term of five consecutive years, commencing from the conclusion of the 37th AGM until the end of the 42nd AGM scheduled for FY31.

Voting results breakdown

According to the consolidated report by scrutinizer Rahul Gori, all three resolutions received 100% votes in favor. A total of 52 members cast their votes remotely, representing 2,649,789 shares. No members voted against or abstained from any resolution.

Item No. Resolution Votes For Votes Against % In Favor
1 Adoption of FY26 financial statements 2,649,789 0 100%
2 Reappointment of Zaver Shankarlal Bhanushali 2,649,789 0 100%
3 Appointment of Raman S Shah & Co as auditors 2,649,789 0 100%

The remote e-voting period opened on September 24, 2026, at 9:00 am and closed on September 27, 2026, at 5:00 pm. The cut-off date for identifying eligible members was September 21, 2026.

Meeting proceedings

Ms. Zaver Bhanushali, Managing Director, chaired the session which commenced at 10:30 am and concluded by 10:40 am. Siddharth Bhanushali coordinated the meeting, ensuring requisite quorum was present throughout the proceedings.

Voting was conducted via remote e-voting through Purva Shareregistry (India) Pvt Ltd. Members who did not vote remotely were allowed to cast their votes electronically during the live virtual meeting. The electronic data and relevant records were sealed and handed over to the Company Secretary for safekeeping.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.50%+3.22%+3.53%+6.02%+8.32%-31.38%

How will the change in statutory auditors to Raman S Shah & Co potentially impact Caprolactam Chemicals' future financial reporting standards and audit transparency?

What are the projected revenue growth and margin trends for Caprolactam Chemicals in FY27 given the approved FY26 standalone financials?

How does the continued leadership of Zaver Shankarlal Bhanushali influence the company's strategic direction regarding caprolactam market expansion or diversification?

like18
dislike

Caprolactam Chemicals closes trading window from October 1 for Q2FY27 results

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026, for Q2FY27 results
  • Restriction applies until 48 hours after result declaration
  • Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Board meeting date for results declaration to be announced later
powered bylight_fuzz_icon
52219806

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Ltd. has announced the closure of its trading window effective October 1, 2026. This restriction applies to designated persons and will remain in force until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026.

The move is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and BSE Circular No. List/Comp/01/2019-20 dated April 2, 2019. The company has formally intimated all designated persons that they must refrain from dealing in the company's securities during this period.

Regulatory compliance and timeline

The closure of the trading window is a standard procedural step to prevent insider trading while sensitive financial information is being compiled and reviewed. The specific period of restriction begins on October 1, 2026, and ends only after the public disclosure of the results.

Event Date
Trading window closure start October 1, 2026
Reporting period end September 30, 2026
Trading window reopens 48 hours after result declaration

Board meeting schedule

The date for the board meeting to approve and declare the financial results for the quarter and half year ended September 30, 2026, has not yet been finalized. The company stated that the board meeting date will be intimated in due course. Until then, the trading restrictions remain strictly enforced for all designated persons as defined under the regulatory framework.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.50%+3.22%+3.53%+6.02%+8.32%-31.38%

When will Caprolactam Chemicals Ltd. announce the specific date for the board meeting to approve the September 2026 financial results?

How might the delayed board meeting schedule impact investor sentiment and trading volume once the window reopens?

Are there any pending regulatory filings or disclosures expected from the company during the closed trading period?

like18
dislike

More News on Caprolactam Chemicals

1 Year Returns:+8.32%